Back to calendar
Cullinan Therapeutics, Inc. (CGEM) Earnings
CGEM reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.85
Actual EPS: $-0.81
EPS surprise: -1.34%
Company overview
Market Cap$1.4B
PriceUSD 22.07
EPS (TTM)-3.39
52-week high23.19
52-week low5.68
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees109